Amphotericin B
1 NDC across 1 manufacturer|1 Generic,0 Brand
Amphotericin B is used to treat aids-related opportunistic infections, aspergillosis, blastomycosis, candidiasis, chronic mucocutaneous candidiasis and cutaneous candidiasis, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
The brand product was first FDA-approved before 1982, and the first generic was approved Jan 1, 1982. FDA's Orange Book lists 5 AB-rated (therapeutically equivalent) products for this ingredient. In 2024, Medicare Part D spent $22K on Amphotericin B across 125 claims for 44 beneficiaries.
Amphotericin B is available as 1 NDC from 1 manufacturer (1 generic, 0 brand), with NADAC prices from $20.87 to $20.87 per EA. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
1
1G / 0B
Manufacturers
1
competing in market
Price Spread
$20.87 – $20.87
per EA
7d Activity
avg +0.0% WoW · of 1 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Explore this market from other angles
Move from the molecule page into the supplier, class, and trend views that create the strongest internal-link cluster for this market.
Top supplier
XGen Pharmaceuticals DJB, Inc. manufacturer profile
Open the supplier page for the manufacturer with the strongest footprint in this market.
Lead class
Polyene Antifungal class view
See how this market rolls up into the broader therapeutic class and compare other drugs in the same bucket.
Trend hub
Latest market trends
Move from this single molecule into the current cross-market mover and volatility view.
Guide
How to interpret NADAC
Review the benchmark methodology behind the prices and spreads shown on this market page.
Manufacturer Breakdown
1 manufacturer producing AMPHOTERICIN B
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
AMPHOTERICIN B 50 MG VIAL | $20.8740 per EA | — |
Frequently Asked Questions
What is Amphotericin B used to treat?
Amphotericin B is used to treat aids-related opportunistic infections, aspergillosis, blastomycosis, candidiasis, chronic mucocutaneous candidiasis and cutaneous candidiasis, per the National Library of Medicine's MED-RT classification.
When did Amphotericin B become available as a generic?
FDA approved the first generic Amphotericin B (ANDA) on Jan 1, 1982. The Orange Book currently lists 5 AB-rated products for this ingredient, meaning FDA considers them therapeutically equivalent to the brand.
How much does Medicare spend on Amphotericin B?
In 2024, Medicare Part D spent $22K on Amphotericin B across 125 claims for 44 beneficiaries.
How many Amphotericin B products are on the market?
The Amphotericin B drug market contains 1 NDC from 1 manufacturer — 1 generic and 0 brand products.
What is the price range for Amphotericin B?
NADAC reference prices for Amphotericin B range from $20.8740 to $20.8740 per EA.
Which manufacturers make Amphotericin B?
1 manufacturer lists Amphotericin B in NADAC. Ranked by number of NDCs, the largest are XGen Pharmaceuticals DJB, Inc. (1).